Skip to content

EV / EBITDA at other companies

ResMed logo
ResMedRMD
15.2×-3.1×
LivaNova logo
LivaNovaLIVN
13.6×+3.1×
Globus Medical logo
Globus MedicalGMED
13.8×-4.9×
Stryker logo
StrykerSYK
22.1×-11.8×
ITG
Integer HoldingsITGR
13×-3.4×
Medtronic logo
MedtronicMDT
13.9×-1.5×

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Calculated from Inspire Medical Systems’s reported figures.

Based on the most recent quarter.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's EV / EBITDA?
Inspire Medical Systems (INSP) reported EV / EBITDA of 21× in Q1 2026.
How has Inspire Medical Systems's EV / EBITDA changed year-over-year?
Inspire Medical Systems's EV / EBITDA decreased by 73.9% year-over-year, from 80.6× to 21×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.